IL36239A - 4-הידרוכסי-4-)2-אוכסו-3- טטראהידרופוריל(פיפרידין והכנתו - Google Patents
4-הידרוכסי-4-)2-אוכסו-3- טטראהידרופוריל(פיפרידין והכנתוInfo
- Publication number
- IL36239A IL36239A IL6836239A IL3623968A IL36239A IL 36239 A IL36239 A IL 36239A IL 6836239 A IL6836239 A IL 6836239A IL 3623968 A IL3623968 A IL 3623968A IL 36239 A IL36239 A IL 36239A
- Authority
- IL
- Israel
- Prior art keywords
- formula
- hydroxy
- tetrahydrofuryl
- oxo
- piperidine
- Prior art date
Links
- GATQULLZZYQJBS-UHFFFAOYSA-N 3-(4-hydroxypiperidin-4-yl)oxolan-2-one Chemical compound OC1(CCNCC1)C1C(OCC1)=O GATQULLZZYQJBS-UHFFFAOYSA-N 0.000 title description 2
- 238000002360 preparation method Methods 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims description 11
- -1 alkali metal amide Chemical class 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical group [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000005909 Kieselgur Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- OVDFZFFHWZEWCI-UHFFFAOYSA-N 3-piperidin-1-yloxolan-2-one Chemical compound O=C1OCCC1N1CCCCC1 OVDFZFFHWZEWCI-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 208000036366 Sensation of pressure Diseases 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 238000006264 debenzylation reaction Methods 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical group 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH558967A CH497458A (de) | 1967-04-19 | 1967-04-19 | Verfahren zur Herstellung neuer Phenothiazin-Derivate |
| CH1705667 | 1967-12-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL36239A true IL36239A (he) | 1971-06-23 |
Family
ID=25698043
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL6829842A IL29842A (he) | 1967-04-19 | 1968-04-17 | תולדות של פנותיאזין |
| IL6836239A IL36239A (he) | 1967-04-19 | 1968-04-17 | 4-הידרוכסי-4-)2-אוכסו-3- טטראהידרופוריל(פיפרידין והכנתו |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL6829842A IL29842A (he) | 1967-04-19 | 1968-04-17 | תולדות של פנותיאזין |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US3531480A (he) |
| AT (2) | AT292726B (he) |
| AU (2) | AU5480273A (he) |
| BE (1) | BE713802A (he) |
| BG (1) | BG17326A3 (he) |
| CH (1) | CH497458A (he) |
| DE (1) | DE1770218A1 (he) |
| ES (1) | ES352822A1 (he) |
| FR (1) | FR1583822A (he) |
| GB (2) | GB1223314A (he) |
| IE (2) | IE32169B1 (he) |
| IL (2) | IL29842A (he) |
| NL (1) | NL6804983A (he) |
| NO (1) | NO124997B (he) |
| OA (1) | OA03386A (he) |
| RO (1) | RO54395A (he) |
| SE (2) | SE361884B (he) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3857943A (en) * | 1969-03-27 | 1974-12-31 | May & Baker Ltd | New phenothiazine derivatives in the treatment of spasticity of muscles |
| CH511885A (de) * | 1969-07-08 | 1971-08-31 | Sandoz Ag | Verfahren zur Herstellung neuer Furanonderivate |
| US6310059B1 (en) * | 1998-06-30 | 2001-10-30 | Neuromed Technologies, Inc. | Fused ring calcium channel blockers |
| US20040259866A1 (en) * | 1998-06-30 | 2004-12-23 | Snutch Terrance P. | Calcium channel blockers comprising two benzhydril moieties |
| US8362021B2 (en) * | 2006-05-11 | 2013-01-29 | Zalicus Pharmaceuticals Ltd. | Method for increasing the bioavailability of benzhydryl piperazine containing compounds |
| EP2654726A1 (en) | 2011-03-08 | 2013-10-30 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
| US8409560B2 (en) | 2011-03-08 | 2013-04-02 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1212031A (fr) * | 1957-10-21 | 1960-03-21 | Rhone Poulenc Sa | Dérivés de la phénothiazine substitués à l'azote par une chaîne basique comportant un hétérocycle et leur préparation |
-
1967
- 1967-04-19 CH CH558967A patent/CH497458A/de not_active IP Right Cessation
-
1968
- 1968-03-11 GB GB01783/68A patent/GB1223314A/en not_active Expired
- 1968-03-11 GB GB40359/70A patent/GB1223315A/en not_active Expired
- 1968-04-09 NL NL6804983A patent/NL6804983A/xx unknown
- 1968-04-10 SE SE05102/71A patent/SE361884B/xx unknown
- 1968-04-10 SE SE04843/68A patent/SE356520B/xx unknown
- 1968-04-16 NO NO681425A patent/NO124997B/no unknown
- 1968-04-17 ES ES352822A patent/ES352822A1/es not_active Expired
- 1968-04-17 AT AT374668A patent/AT292726B/de not_active IP Right Cessation
- 1968-04-17 IE IE444/68A patent/IE32169B1/xx unknown
- 1968-04-17 BG BG9805A patent/BG17326A3/xx unknown
- 1968-04-17 IL IL6829842A patent/IL29842A/he unknown
- 1968-04-17 AT AT1201369A patent/AT293372B/de not_active IP Right Cessation
- 1968-04-17 IE IE637/71A patent/IE32170B1/xx unknown
- 1968-04-17 BE BE713802D patent/BE713802A/xx unknown
- 1968-04-17 IL IL6836239A patent/IL36239A/he unknown
- 1968-04-17 DE DE19681770218 patent/DE1770218A1/de active Pending
- 1968-04-17 US US721949A patent/US3531480A/en not_active Expired - Lifetime
- 1968-04-18 FR FR148511A patent/FR1583822A/fr not_active Expired
- 1968-04-18 RO RO196856492A patent/RO54395A/ro unknown
- 1968-04-19 OA OA53262A patent/OA03386A/xx unknown
-
1973
- 1973-04-19 AU AU54802/73A patent/AU5480273A/en not_active Expired
- 1973-04-19 AU AU54801/73A patent/AU5480173A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IE32170L (en) | 1968-10-19 |
| NO124997B (he) | 1972-07-03 |
| BE713802A (he) | 1968-10-17 |
| IE32169B1 (en) | 1973-05-02 |
| CH497458A (de) | 1970-10-15 |
| US3531480A (en) | 1970-09-29 |
| AT292726B (de) | 1971-09-10 |
| DE1770218A1 (de) | 1971-10-14 |
| AT293372B (de) | 1971-10-11 |
| RO54395A (he) | 1973-02-17 |
| SE356520B (he) | 1973-05-28 |
| NL6804983A (he) | 1968-10-21 |
| BG17326A3 (he) | 1973-07-25 |
| IL29842A (he) | 1971-05-26 |
| GB1223315A (en) | 1971-02-24 |
| OA03386A (fr) | 1970-12-15 |
| GB1223314A (en) | 1971-02-24 |
| IE32169L (en) | 1968-10-19 |
| IE32170B1 (en) | 1973-05-02 |
| ES352822A1 (es) | 1969-11-16 |
| FR1583822A (he) | 1969-12-05 |
| AU5480273A (en) | 1973-07-12 |
| AU5480173A (en) | 1973-07-12 |
| SE361884B (he) | 1973-11-19 |
| IL29842A0 (en) | 1968-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO140977B (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner | |
| NO125911B (he) | ||
| JPS6113472B2 (he) | ||
| IE43847B1 (en) | N-substituted phenyl-piperidine derivatives | |
| SU843749A3 (ru) | Способ получени 4а,9в-транс- гЕКСАгидРО- -КАРбОлиНА | |
| US3501487A (en) | Certain hetero-aryl lower alkylene derivatives of 1 - lower alkyl - 2-imino-pyrrolidines | |
| US2678317A (en) | N - benzhydryltropylamine com | |
| US4087426A (en) | Oxybisberberine and a process for its production | |
| Santilli et al. | 8, 9, 10, 11-Tetrahydro-12H-benzo [5, 6] quinoxalino-[2, 3-e][1, 4] diazepin-12-ones. Examples of a New Heterocyclic Ring System | |
| Akkerman et al. | Synthetic oxytocics. IV. 3‐(piperidyl‐(2)‐methyl‐) indoles and related compounds | |
| US3072648A (en) | X-phenyl-s | |
| US2951080A (en) | Novel phenyl-substituted piperidines | |
| US3462443A (en) | Indeno(1,2-c)pyridine derivatives | |
| US3073826A (en) | 3-pyrrolidylmethyl-4-quinazolones | |
| US3324139A (en) | 3-(3-hydroxyphenyl)-1-phenacylpiperidine compounds | |
| US3037986A (en) | 2-(para-methoxyphenylcarbinol)-1-(phenylalkyl) piperidinium hydrobromide | |
| US3531480A (en) | Phenothiazine derivatives | |
| GRUNDMANN et al. | Triazines. XVII. s-Triazine from s-Triazine-2, 4, 6-tricarbonic Acid | |
| US2931805A (en) | Spiro [bicyclo [2. 2. 1] heptane-2, 2'-alkylenimines] | |
| US3086972A (en) | Aza-thiaxanthene derivatives | |
| US3422110A (en) | Ergot alkaloids methylated in the 10a'-position | |
| NO139050B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater | |
| Belleau | SYNTHESIS IN THE FIELD OF THE ERYTHRINA ALKALOIDS: PART II. APPROACHES TO THE RING SYSTEM OF β-ERYTHROIDINE | |
| Camparini et al. | Synthesis and structure of dihydro‐1, 2, 4‐triazin‐6 (1H) ones | |
| US3536720A (en) | 2,2,6,6-tetrasubstituted-4-substituted-methylene piperidine-1-oxides |